-
Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald
ソース: Buzz FX / 06 3 2025 07:32:12 America/Chicago
Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald Written by MarketBeat March 6, 2025 Share Link copied to clipboard. Aclaris Therapeutics ( NASDAQ:ACRS - Get Free Report ) was upgraded by analysts at Ca
Read more...